award

ULK1 Inhibitor in Combination with Immune Checkpoint Blockade in PancreaticCancer

  • Award Number: R21CA270588

  • ORGANIZATION: NATIONAL CANCER INSTITUTE

  • OPDIV: NIH

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

  • PERIOD OF PERFORMANCE START DATE: 12/09/2022

  • PERIOD OF PERFORMANCE END DATE: 11/30/2025